Question 1

What is Design Therapeutics, Inc.'s total liabilities?

Accepted Answer

Design Therapeutics, Inc. (DSGN) reported total liabilities of $12.39M in Q1 2026.

Question 2

How has Design Therapeutics, Inc.'s total liabilities changed year-over-year?

Accepted Answer

Design Therapeutics, Inc.'s total liabilities increased by 29.6% year-over-year, from $9.56M to $12.39M.

Question 3

What is the long-term trend for Design Therapeutics, Inc.'s total liabilities?

Accepted Answer

Over 5 years (2020 to 2025), Design Therapeutics, Inc.'s total liabilities has grown at a 40.8% compound annual growth rate (CAGR), from $2.48M to $13.7M.

Question 4

What does total liabilities mean?

Accepted Answer

The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.

Line item	March 31, 2026	December 31, 2025
Accrued expenses and other current liabilities (including related party amounts of $890 as of December 31, 2025)	7,914	10,743
Total current liabilities	10,190	13,055
Operating lease liability	2,198	645
Total liabilities	12,388	13,700
Commitments and contingencies (See Note 8)
Stockholders’ equity:
Common stock, $0.0001 par value; 200,000,000 shares authorized at March 31, 2026 and December 31, 2025; 62,441,429 and 60,398,051 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively	6	6
Additional paid-in capital	532,958	509,100

Total Liabilities at other companies

Other financials

Income statement

Balance sheet

Cash flow

Valuation

Profitability

Returns & leverage

Where this comes from

FAQ

Ask your AI about Design Therapeutics, Inc.'s total liabilities.

Design Therapeutics, Inc. DSGN Total Liabilities